The novel MKL target gene myoferlin modulates expansion and senescence of hepatocellular carcinoma
Authors:
- 23 January 2017
- journal article
- Published by Springer Nature in Oncogene
- Vol. 36 (24) , 3464-3476
Abstract
Megakaryoblastic Leukemia 1 and 2 (MKL1/2) are transcriptional coactivators of Serum Response Factor (SRF) with an essential role for hepatocellular carcinoma (HCC) growth and oncogene-induced senescence. In this report, we identified myoferlin as a novel MKL/SRF target gene by gene expression profiling and verification in vivo in HCC xenografts. Myoferlin was overexpressed in human and murine HCCs triggered by conditional expression of constitutively active SRF-VP16 protein in hepatocytes. Furthermore, myoferlin was required for HCC cell invasion, proliferation and anchorage-independent cell growth. We provide evidence that myoferlin is a crucial gene target of MKL1/2 mediating its effect on oncogene-induced senescence by modulating the activation state of the EGFR and downstream MAPK and p16-/Rb pathways. Depletion of myoferlin in tumour cells from SRF-VP16-derived murine HCCs induced a senescence phenotype. These findings identify MKL1/2 and myoferlin as novel therapeutic targets to treat human HCC by a senescence-inducing strategy.Keywords
This publication has 34 references indexed in Scilit:
- Depletion of the transcriptional coactivators megakaryoblastic leukaemia 1 and 2 abolishes hepatocellular carcinoma xenograft growth by inducing oncogene‐induced senescenceEMBO Molecular Medicine, 2013
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics DataCancer Discovery, 2012
- The transcriptional coactivators megakaryoblastic leukemia 1/2 mediate the effects of loss of the tumor suppressor deleted in liver cancer 1Oncogene, 2011
- A Unique Metastasis Gene Signature Enables Prediction of Tumor Relapse in Early-Stage Hepatocellular Carcinoma PatientsCancer Research, 2010
- The role of serum response factor in hepatocellular carcinoma: Implications for disease progressionInternational Journal of Oncology, 2010
- Linking actin dynamics and gene transcription to drive cellular motile functionsNature Reviews Molecular Cell Biology, 2010
- Polyethylenimine/small interfering RNA‐mediated knockdown of vascular endothelial growth factor in vivo exerts anti‐tumor effects synergistically with BevacizumabThe Journal of Gene Medicine, 2010
- MicroRNA-122 Inhibits Tumorigenic Properties of Hepatocellular Carcinoma Cells and Sensitizes These Cells to SorafenibJournal of Biological Chemistry, 2009
- DLC1 is a chromosome 8p tumor suppressor whose loss promotes hepatocellular carcinomaGenes & Development, 2008
- Actin Dynamics Control SRF Activity by Regulation of Its Coactivator MALCell, 2003